Chemocentryx, Inc.
(NASDAQ : CCXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.34%176.901.2%$602.87m
GILDGilead Sciences, Inc.
-0.57%67.630.9%$539.35m
BIIBBiogen Inc.
-0.07%280.201.2%$518.93m
CELGCelgene Corporation
-3.55%75.591.2%$495.49m
REGNRegeneron Pharmaceuticals, Inc.
-1.60%296.982.6%$311.73m
ALXNAlexion Pharmaceuticals, Inc.
-1.81%118.882.0%$248.67m
ILMNIllumina, Inc.
-0.12%269.343.5%$244.02m
VRTXVertex Pharmaceuticals Incorporated
-0.37%156.661.9%$235.66m
NKTRNektar Therapeutics
-1.51%84.016.0%$208.97m
AAgilent Technologies, Inc.
2.16%65.711.5%$203.35m
INCYIncyte Corporation
-0.56%67.452.5%$193.42m
SRPTSarepta Therapeutics, Inc.
-3.11%90.5716.6%$127.20m
EXASExact Sciences Corporation
-0.31%52.2025.5%$115.71m
BMRNBioMarin Pharmaceutical Inc.
0.56%89.384.4%$115.07m
ALNYAlnylam Pharmaceuticals, Inc
-1.66%101.109.8%$101.94m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.